Luye Pharma : POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 8 JUNE 2016 AND RETIREMENT OF NON-EXECUTIVE DIRECTORS

44223-01A 1..3

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

LUYE PHARMA GROUP LTD.

綠 葉 製 藥 集 團 有 限 公 司

(incorporated in Bermuda with limited liability)

(Stock Code: 02186)

POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 8 JUNE 2016

AND

RETIREMENT OF NON-EXECUTIVE DIRECTORS

Reference is made to the circular (the ''Circular'') issued by Luye Pharma Group Ltd. (the ''Company'') on 10 May 2016. Unless the context otherwise requires, capitalised terms used in this announcement have the same meaning as defined in the Circular.

At the annual general meeting (the ''AGM'') held on 8 June 2016, a poll was demanded by the chairman of the AGM for voting on all the proposed resolutions as set out in the notice of the AGM dated 10 May 2016 (the ''AGM Notice'').

As at the date of the AGM, the total number of issued shares of the Company was 3,321,073,843 shares of US$0.02 each, being the total number of Shares entitling the Shareholders to attend and vote for or against the resolutions at the AGM. There were no restrictions on any Shareholders casting vote on any of the proposed resolutions at the AGM. No Shareholder was required to attend and vote only against the proposed resolutions at the AGM.

The Company's Hong Kong branch share registrar, Computershare Hong Kong Investor Services Limited, was appointed as the scrutineer at the AGM for the purpose of vote-taking. All the resolutions, where were voted on by poll, were approved by Shareholders.

The poll results in respect of the respective resolutions proposed at the AGM were as follow:

ORDINARY RESOLUTIONS (Note)		Number of votes cast and approximate percentage of total number of votes cast
		For	Against
1.	To receive and adopt the audited consolidated financial statements of the Company and the reports of the Directors and the auditors of the Company (the ''Auditors'') for the year ended 31 December 2015.	2,309,097,488 100.000000%	0 0.000000%
2.	(a) To re-elect Mr. LIU Dian Bo as an executive Director.	2,226,575,748 96.601021%	78,343,740 3.398979%
	(b) To authorise the Board to fix the remuneration of the Directors.	2,303,054,718 99.986330%	314,870 0.013670%
3.	To re-appoint Ernst & Young as the Auditors and authorise the Board to fix their remuneration for the year ending 31 December 2016.	2,309,097,488 100.000000%	0 0.000000%
4.	(A) To give a general mandate to the Directors to allot, issue and deal with additional shares not exceeding 20% of the issued share capital of the Company.	1,943,665,735 84.174261%	365,431,753 15.825739%
	(B) To give a general mandate to the Directors to repurchase shares not exceeding 10% of the issued share capital of the Company.	2,309,097,488 100.000000%	0 0.000000%
	(C) To extend the Issue Mandate by the number of shares repurchased by the Company.	1,944,278,143 84.200782%	364,819,345 15.799218%

Note: For the full text of the above resolutions, please refer to the AGM Notice as set out in the Circular.

As more than 50% of votes were casted in favour of the above resolutions, all resolutions were duly passed as ordinary resolutions.

RETIREMENT OF NON-EXECUTIVE DIRECTORS

The Board announces that Mr. Pan Jian, Mr. Liu Dong and Ms. Wang Xin did not offer themselves for re-election as non-executive Directors at the AGM due to their business engagement/arrangements, and accordingly, they retired from office as the non-executive Directors upon the conclusion of the AGM.

Mr. Pan Jian, Mr. Liu Dong and Ms. Wang Xin have confirmed that they have no disagreement with the Board and there is no matter that needs to be brought to the attention of the Shareholders in relation to their retirement from the Board.

The Board would like to express its appreciation and gratitude to each of Mr. Pan Jian, Mr. Liu Dong and Ms. Wang Xin for their invaluable contribution to the Company during their tenure of service.

By order of the Board

LUYE PHARMA GROUP LTD.

Liu Dian Bo

Chairman

Hong Kong, 8 June 2016

As at the date of this announcement, the executive Directors are Mr. LIU Dian Bo, Mr. YANG Rong Bing, Mr. YUAN Hui Xian and Ms. ZHU Yuan Yuan; and the independent non-executive Directors are Mr. ZHANG Hua Qiao, Professor LO Yuk Lam, Mr. LEUNG Man Kit and Mr. CHOY Sze Chung Jojo.